Robert Iannone
CIK 1737329 · EVP, Global Head of R&D & CMO · last filed 2026-03-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.49M
Companies
4
Total Filings
35
Lifetime Open-Market Net
-$2.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JAZZ | EVP, Global Head of R&D & CMO | 88,871 | $230.56 | $20.49M | -$2.80M | 22 | 2026-03-09 |
| iTeos Therapeutics, Inc. (ITOS) Delisted | Director | — | $10.15 | — | $0 | 5 | 2024-06-13 |
| Jounce Therapeutics, Inc. (JNCE) Delisted | Director | — | $1.88 | — | $0 | 6 | 2023-05-04 |
| IMMUNOMEDICS INC (IMMU) Delisted | CHIEF MEDICAL OFFICER | — | — | — | $0 | 2 | 2019-03-18 |
Recent Filings · Page 3 of 4
35 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-09 | JAZZ | Mixed | +10,047 | -$204.3K | EDGAR |
| 2021-06-22 | Jounce Therapeutics, Inc. (JNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-21 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-09 | JAZZ | Tax (F) | −1,206 | -$212.8K | EDGAR |
| 2021-05-03 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-09 | JAZZ | Tax (F) | −741 | -$122.1K | EDGAR |
| 2021-03-01 | JAZZ | Grant (A) | +8,535 | $0 | EDGAR |
| 2020-07-02 | Jounce Therapeutics, Inc. (JNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-29 | Jounce Therapeutics, Inc. (JNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-05 | JAZZ | Tax (F) | −943 | -$113.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.